SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences reports 3% rise in Q1 consolidated net profit

13 Aug 2025 Evaluate

Zydus Lifesciences has reported result for first quarter ended June 30, 2025 (Q1FY26).

The company has reported 77.38% fall in its net profit at Rs 384.70 crore for the quarter ended June 30, 2025 as compared to Rs 1700.80 crore for the same quarter in the previous year. The total income of the company decreased by 35.66% at Rs 2745.40 crore for Q1FY26 as compared to Rs 4266.80 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 3.30% rise in its net profit at Rs 1466.80 crore for Q1FY26 as compared to Rs 1419.90 crore for the same quarter in the previous year. The total income of the company increased by 7.30% at Rs 6728.60 crore for Q1FY26 as compared to Rs 6270.70 crore for the corresponding quarter previous year.

Zydus Lifesciences Share Price

923.10 7.65 (0.84%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×